The Finance Weekly

APRIL 1, 2023

However, amidst this uncertainty, the need for qualified CFOs remains as crucial as ever. CFO Pros on the Move March 2023 Steve Nave | Funko Funko, the pop-culture toy company, has named , Steve Nave as its CFO and COO. Burke takes over from Brian Cooper, who assumed the CFO role in 2021. She is also a U.S. Army veteran.

CFO 52

CFO Corporate Finance Finance Pharmaceutical 52

CFO News Room

FEBRUARY 4, 2022

. “Everyone’s back to playing leap frog over each other to see how hawkish they can get about what the Fed’s going to do, when the Fed probably doesn’t even know itself,” said Art Hogan, chief market strategist at National Securities. Markets could remain volatile in the coming week. More volatility.

Marketing 130

Marketing Healthcare Pharmaceutical Communication 130

CFO News

APRIL 7, 2024

In the Indian corporate banking scene, Citigroup's global head of corporate banking Jason Rekate highlighted the prominence of companies in infrastructure, pharmaceuticals, and automobiles.

Pharmaceutical 40

Pharmaceutical Banking Marketing Investments 40

CFO News

DECEMBER 22, 2022

Industry executives and headhunters told ET that salesforce is needed as they launch more products targeting chronic therapeutic segments such as diabetes, heart failure, central nervous system and respiratory.

Pharmaceutical 52

Pharmaceutical Sales Marketing 52

CFO News Room

NOVEMBER 11, 2022

Thus, it includes not only the direct costs of producing the product or service the firm sells, but also other expenses associated with operations, including S, G & A expenses and marketing costs. billion assessed by accountants.

Accounting 130

Accounting Marketing Advertising Valuation 130

CFO News Room

DECEMBER 17, 2022

American biotech, pharmaceutical, and life sciences companies face myriad challenges today. For a life sciences company, global expansion can be particularly daunting, given the costs and time involved in navigating procedures and regulations that vary from one market to the next. © Boehringer Ingelheim, Dieter Quant.

Pharmaceutical 130

Pharmaceutical Healthcare Education Manufacturing 130

CFO News Room

JANUARY 10, 2023

Regeneron Pharmaceuticals — The stock was up 2.9%, a day after the shares dropped about 7.7% on news that sales of the pharmaceutical company’s Eylea drug were hurt by a shift to an off-label competitor in the final quarter of 2022. following an upgrade to overweight from sector weight at KeyBanc Capital markets.

Pharmaceutical 130

Pharmaceutical GAAP Leadership Manufacturing 130

CFO News Room

JANUARY 18, 2023

That said, about 31% of the net profits of all publicly traded firms listed globally in 2021 were generated by financial service firms; that percent is lower in the US and higher in emerging markets. IFRS and GAAP now treat as leases as debt, but that is still not the case in many other markets that are not covered by either standard).

Marketing 130

Marketing Hurdle Rate Investments Accounting 130

CFO News Room

NOVEMBER 16, 2022

In my first two posts on Facebook, I noted that its most recent earnings report, and the market reaction to it, offers an opportunity for us to talk about bigger issues. If you are a number cruncher like me, you will find that adding a story to your valuation will only augment your number skills and improve your valuations.

Marketing 130

Marketing Valuation Advertising Numbers 130

CFO News Room

JANUARY 6, 2023

Federal Trade Commission guidelines for advertising health-related products just got a big refresh—and they could be a rude awakening for marketers making overzealous claims about products such as supplements or health apps. . CMO Today delivers the most important news of the day for media and marketing professionals.

Marketing 100

Marketing Advertising Budgeting Compliance 100

CFO News

JUNE 9, 2023

According to Charu Sehgal, the market expectations are on similar lines as indicated by the stock prices which for many pharma companies had risen by 20-30% in Apr’20 compared to the Q3FY20 period.

Pharmaceutical 52

Pharmaceutical Marketing 52

CFO Simplified

MAY 14, 2024

Think of restaurants, grocery stores, pharmaceutical companies. In the pharmaceutical industry, drugs have a certain shelf life before they become unsafe, or their efficacy is reduced. This is used by Consulting firms, Law Firms, Medical Practices, Marketing agencies, Banks. It cannot be stored, transferred, or used later.

Profit and Loss 52

Profit and Loss Pharmaceutical Manufacturing Vendor Management 52

CFO News Room

NOVEMBER 11, 2022

GSK — Shares of the pharmaceutical company dropped 6.2% Ralph Lauren — The clothing maker popped 7.7% after it reported better-than-expected second quarter earnings. UBS called the company a “turnaround stock,” noting useful changes to its business model. Among the laggards were Cigna (down 9.3%), Elevance (7.7%

Profit and Loss 130

Profit and Loss Pharmaceutical Construction Entertainment 130

CFO News Room

DECEMBER 28, 2022

Kala Pharmaceuticals — The biopharmaceutical company surged more than 200% following the Food and Drug Administration’s acceptance of an investigational new drug application for its potential treatment for persistent corneal epithelial defect. The firm gave the stock a price target of $29, which presents an upside of 75.4%

Entertainment 130

Entertainment Pharmaceutical Technology Securities 130

CFO News

APRIL 14, 2024

Indian M&A activity set to rise to $75 billion in 2024, driven by private equity, IT, core industrial space, and pharmaceuticals, with influences from cross-border deals, M&A valuations, equity, debt markets, and IPOs.

Pharmaceutical 40

Pharmaceutical Valuation Marketing 40

CFO News Room

JANUARY 9, 2023

Regeneron – Regeneron slipped 5% after the pharmaceutical company said that sales of its Eylea drug were negatively impacted in the final quarter of 2022 by a shift to an off-label competitor. Ceridian HCM — Ceridian HCM shares rose 5%. Monolithic Power Systems – Shares of Monolithic Power Systems gained 6.4%

Pharmaceutical 130

Pharmaceutical Restructuring Banking Marketing 130

CFO News Room

JANUARY 18, 2023

Hunt Transport Services — The transportation stock jumped 4% after executives said on an earnings call that they expect to see the freight market rebound in second quarter going into third quarter as inventory resets. Moderna — Shares rose 2.7% Net income was down from the third quarter, in part due to a higher provision for credit losses.

Transportation 130

Transportation Pharmaceutical Education Economics 130

PYMNTS

NOVEMBER 19, 2020

19), Kehoe wasn’t fussed about the dramatic shock to the stock market once Amazon debuted the service. TJ Parker , vice president of Amazon Pharmacy, said the company's goal is to make a "inject transparency into the market" so customers know exactly what their options are, according to the PYMNTS report.

Pharmaceutical 64

Pharmaceutical CFO Healthcare Accounting 64

CFO News

OCTOBER 22, 2023

PwC India said 112 organisations from diverse industries, such as telecommunications, industrial products and manufacturing, financial services, banking and capital markets, automotive, education, healthcare, and pharmaceuticals, were surveyed. "The

Pharmaceutical 52

Pharmaceutical Healthcare Education Manufacturing 52

CFO News

SEPTEMBER 21, 2023

Glenmark Pharma’s stake in the leading active pharmaceutical ingredient (API) platform will drop to 7.84% from 82.84%. crore, a slight discount to the current market value of Rs 7,683 crore. The transaction values the company at Rs 7,535.4

Pharmaceutical 52

Pharmaceutical Marketing 52

CFO News Room

NOVEMBER 13, 2022

Additionally, Morgan Stanley reiterated it as overweight, noting hardware subscriptions as a key catalyst for moving the market toward a loan-to-value valuation. AstraZeneca – The pharmaceutical company added 6.6% Apple – Shares of the technology giant gained 8.9% as rates dropped, lifting the broader tech sector.

Profit and Loss 130

Profit and Loss Pharmaceutical Forecasting Valuation 130

CFO News

SEPTEMBER 15, 2023

Dr Reddy's Laboratories (DRL) and Intas Pharmaceuticals, both Indian companies, are reportedly in the race to acquire the biosimilar products portfolio of Biogen, a US-based biotech company. DRL has been aggressively expanding its biosimilars portfolio globally and has launched several products in India and emerging markets.

Pharmaceutical 52

Pharmaceutical Marketing 52

CFO News

SEPTEMBER 4, 2023

Private equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the promoters of Cipla, the Hamied family. If DRL decides to participate, the combined entity would become the leading Indian-origin pharma major at home and in the US and emerging markets.

Pharmaceutical 52

Pharmaceutical Marketing 52

CFO News

MAY 10, 2023

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Pharmaceutical 52

Pharmaceutical Healthcare Manufacturing Marketing 52

Future CFO

DECEMBER 3, 2023

Organisations are actively investing in cloud technology due to its potential to foster innovation, create market disruptions, and enhance customer retention in order to gain a competitive edge,” Govekar said. The post Cloud computing to be business necessity in 2028 appeared first on FutureCFO.

Pharmaceutical 52

Pharmaceutical Manufacturing Leverage Technology 52

VCFO

MAY 11, 2023

Founded in 1996, vcfo pioneered the concept of the “Virtual CFO” with its original core offering of fractional or part-time CFO solutions. About vcfo vcfo provides an integrated suite of finance, HR and recruiting support, including outsourcing and consulting solutions that improve operational performance and optimize productivity.

Pharmaceutical 40

Pharmaceutical CFO Risk Management Manufacturing 40

CFO News Room

FEBRUARY 5, 2022

Among companies reporting earnings today are Bristol Myers Squibb Company ( BMY ), Cboe Global Markets, Inc. HIG ), and Regeneron Pharmaceuticals, Inc. The plan will hand control of the specialty pharmaceutical company to creditors. .’s ( SNAP ) stock price is 45% higher. Bureau of Labor Statistics. billion opioid deal.

Pharmaceutical 130

Pharmaceutical Advertising Treasury Transportation 130

CFO News

MAY 7, 2023

Mankind Pharma's shares are commanding a premium of Rs 100-113 to its issue price of Rs 1,080 in the grey market. Although Mankind Pharma is the fourth-largest Indian pharmaceutical company in terms of domestic sales, investors are advised to book profits on listing day given the expensive valuations of the stock versus peers.

Pharmaceutical 52

Pharmaceutical Valuation Sales Marketing 52

CFO News Room

FEBRUARY 4, 2022

Check out the companies making headlines before the bell: Regeneron Pharmaceuticals (REGN) – The drugmaker reported adjusted quarterly earnings of $23.72 per share, beating the $18.35 consensus estimate. Revenue also topped the forecast on strong sales of the company’s Covid-19 antibody therapy as well as its eye drug Eylea.

Pharmaceutical 130

Pharmaceutical Forecasting Retail Banking 130

CFO News Room

NOVEMBER 30, 2022

Horizon Therapeutics — The pharmaceutical company’s shares soared 26% after Horizon said it was in preliminary talks about a possible sale with several large pharma companies, including Amgen, Sanofi and Johnson & Johnson’s Janssen Global Services unit. Stifel downgraded the stock to hold from buy after the earnings report.

Pharmaceutical 130

Pharmaceutical Forecasting Sales Retail 130

CFO News Room

JANUARY 20, 2023

” Eli Lilly — Shares of the pharmaceutical company fell more than 2% after the U.S. .” Coinbase — The crypto services firm climbed 6.6% Food and Drug Administration rejected the drugmaker’s experimental Alzheimer’s disease treatment as it had not provided enough trial data.

Profit and Loss 130

Profit and Loss Pharmaceutical Manufacturing Forecasting 130

Future CFO

APRIL 11, 2021

The IPO markets in Hong Kong and China are well supported to continue to perform vibrantly in the rest of 2021, thanks to the ample liquidity from various monetary and economic easing measures in the world to dissipate the negative impact brought by the ongoing pandemic, said Deloitte China recently when releasing an outlook report. .

Marketing 40

Marketing Pharmaceutical Economics Valuation 40

PYMNTS

DECEMBER 16, 2020

Chinese healthcare technology group WeDoctor is still planning a massive IPO in Hong Kong in the coming months, despite the recent departure of its CFO, John Cai. Sources told Bloomberg that WeDoctor aims to file an IPO prospectus around the Lunar New Year in February, with hopes to raise $500 million to $1 billion.

Planning 81

Planning Healthcare Pharmaceutical CFO 81

CFO News Room

NOVEMBER 6, 2022

Take a pharmaceutical company that had outsourced its facilities management to a supplier for almost 25 years. While savings and performance targets were being met, the pharmaceutical company was irritated with the supplier’s lack of innovation.

Pharmaceutical 130

Pharmaceutical Communication Accounting Economics 130

CFO News Room

NOVEMBER 1, 2022

Pfizer – Shares of the pharmaceutical giant jumped nearly 3% after the company reported stronger-than-expected earnings and issued an improved financial outlook. Johnson & Johnson is looking to boost growth at its medical devices unit after it completes plans for a spinoff of its consumer health business next year.

Foreign Exchange 130

Foreign Exchange Budgeting Profit and Loss Pharmaceutical 130

CFO News Room

FEBRUARY 5, 2022

Staying with the growth agenda, the government is going to set up an animation, visual effects, gaming, and comics (AVGC) task force to help build domestic capacity to serve the Indian markets and also meet global demand.

Budgeting 100

Budgeting Compliance Pharmaceutical Manufacturing 100

Future CFO

OCTOBER 16, 2019

Companies in most Asia Pacific markets are conservative in setting their salary increase budgets for 2020, said advisory firm Willis Towers Watson recently. Only nine out of 20 markets in WTW’s Q3 survey plan to have a higher salary budget in 2020, the company pointed out. in 2017 to 4.0% in 2018, he observed. in 2020 versus 4.1%

Pharmaceutical 52

Pharmaceutical Budgeting Manufacturing Planning 52